Clinical, bacteriological, and immunological characterisation of ampicillin-resistant Haemophilus influenzae type B.
D000284:Administration, Oral; D000667:Ampicillin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000302:isolation & purification; D002353:Carrier State; D002675:Child, Preschool; D002701:Chloramphenicol / Q000627:therapeutic use; D003631:Day Care, Medical; D005260:Female; D006193:Haemophilus influenzae / Q000187:drug effects* / Q000276:immunology / Q000302:isolation & purification; D006801:Humans; D005779:Immunodiffusion; D007223:Infant; D007275:Injections, Intravenous; D008297:Male; D008583:Meningitis, Haemophilus / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D009305:Nasopharynx / Q000382:microbiology; D010403:Penicillin Resistance; D011863:Radioimmunoassay
D000907:Antibodies, Bacterial; D002701:Chloramphenicol; D000667:Ampicillin